Abstract
Hyperglycaemia in pregnancy (HIP) increases the risk for adverse birth outcomes and predisposes mothers and babies to future chronic metabolic disease. This thesis demonstrates that screening for HIP using an oral glucose tolerance test (OGTT) is a poor fit for rural and remote healthcare settings; the OGTT is inaccurate and uptake is inadequate. Improved screening algorithms using glycated haemoglobin (before 20 weeks gestation) and fasting plasma glucose (after 24 weeks gestation)have the potential to improve screening coverage; expedite detection of the HIP; reduce the burden of OGTT, and improve birth outcomes. These improvements will be critical to reducing the significant intergenerational impact of the HIP.
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Thesis sponsors | |
| Award date | 29 Jun 2022 |
| DOIs | |
| Publication status | Unpublished - 2021 |
Access to Document
- THESIS - DOCTOR OF PHILOSOPHY - JAMIESON, Emma Louise - 2022_
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.